Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma

We investigate the value of pretreatment serologic antienzyme rate (AER) of Epstein-Barr virus (EBV) DNase-specific neutralizing antibody complementing TNM staging in prognostication of nasopharyngeal carcinoma (NPC). Pretreatment serum samples from 1,303 patients with untreated NPC were collected a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2010-12, Vol.28 (35), p.5202-5209
Hauptverfasser:	JIE XU, WAN, Xiang-Bo, ZENG, Yi-Xin, LIU, Quentin, HANG, Xue-Fei, CHAN, K. C. Allen, HONG, Ming-Huang, WANG, Li-Hui, LONG, Zi-Jie, QING LIU, MIN YAN, LO, Y. M. Dennis
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Neutralizing - analysis Antibodies, Neutralizing - blood Antibodies, Viral - blood Antigens, Viral - immunology Biological and medical sciences Carcinoma Deoxyribonucleases - immunology Disease-Free Survival Epstein-Barr virus Epstein-Barr Virus Infections - blood Epstein-Barr Virus Infections - complications Female Herpesvirus 4, Human - immunology Humans Infectious diseases Kaplan-Meier Estimate Male Medical sciences Middle Aged Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms - blood Nasopharyngeal Neoplasms - pathology Nasopharyngeal Neoplasms - virology Neoplasm Staging - methods Prognosis ROC Curve Tumors Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!